John Jasinski
Medical · Norwalk, CTNPI 1598781791
Payments from drug & device makers
Across 1,186 payments — averaging $156.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$58K
- Incyte Corporation$36K
- UCB, Inc.$33K
- AbbVie$17K
- Janssen Scientific Affairs, LLC$15K
- Sun Pharmaceutical Industries Inc.$9K
- plus $17K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 174 | $57,686 |
| Incyte Corporation | 129 | $36,111 |
| UCB, Inc. | 94 | $32,886 |
| AbbVie(2 entities) | 193 | $17,454 |
| Janssen Scientific Affairs, LLC | 21 | $14,750 |
| Sun Pharmaceutical Industries Inc. | 58 | $9,064 |
| Sanofi | 71 | $3,166 |
| Pfizer | 52 | $2,873 |
| LEO Pharma Inc. | 55 | $2,225 |
| Regeneron Healthcare Solutions, Inc. | 91 | $1,916 |
| Novartis | 50 | $1,652 |
| Regeneron | 4 | $1,449 |
| E.r. Squibb & Sons, L.L.C. | 55 | $925 |
| Lilly USA, LLC | 38 | $804 |
| Dermavant Sciences, Inc. | 16 | $352 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 17 | $348 |
| Amgen | 18 | $335 |
| Arcutis Biotherapeutics, Inc. | 13 | $261 |
| Organon | 7 | $220 |
| Galderma Laboratories, L.p. | 9 | $168 |
| Boehringer Ingelheim | 6 | $136 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Blueprint Medicines Corporation | 3 | $72 |
| Biofrontera Inc. | 1 | $69 |
| Botanix SB Inc | 2 | $43 |
| Strata Skin Sciences, Inc. | 4 | $42 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $31 |
| Medtronic | 1 | $25 |
| Journey Medical Corporation | 1 | $15 |
How this compares
$185,159 in reported general payments places this provider in the 95th percentile of 592 medical providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Norwalk
- Shilpa DesaiStamford$215K
- Gregory RauNew Haven$211K
- Brianna PaesanoStamford$153K
- Debra SullivanDerby$100K
- Ryan DonovanNew Haven$75K
- Jonica PagnuccoWaterbury$32K
- Alyssa GreenleafSouthington$26K
- Mark VolpeSuffield$21K
- Josephine DiazSuffield$20K
- Marissa CarignanManchester$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.